Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-001304

Options or other derivatives

  • Chief Operating Officer acquired 1,230,948 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bertrand William C JR · Chief Operating Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-01-04 Grant or award : show line 1 in the form Option to purchase Ordinary Shares +1,006,224 1,006,224 D
2019-01-04 Grant or award : show line 2 in the form Option to purchase Ordinary Shares +224,724 224,724 D
Loading xslF345X03/a4.xml…